Has Quang Vo received payments from drug or device companies?

Yes. Drug and device makers reported $2,594 in general payments to Quang Vo across 30 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Quang Vo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Quang Vo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Quang Vo

Internal Medicine · Surprise, AZNPI 1568568582

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,636 of the $2,594 with a category attached, or 63.1%. 5 manufacturers reported payments, led by Eli Lilly at 36.9% of the total. Reporting peaked in 2023 at $1,560 and has fallen 91.7% since, to $129 in 2025.

$2,594in general payments, 2019–2025

Across 30 payments — averaging $86.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$958
Abbott$886
Actelion Pharmaceuticals US, Inc.$396
Inari Medical, Inc.$227
Bristol Myers Squibb$127

$677,060in research payments, 2019–2025

Across 115 payments — averaging $5887.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$148K
Evofem Biosciences, Inc.$137K
Astrazeneca UK Limited$119K
Welch Allyn$71K
Astellas Pharma Global Development$53K
Pacira Therapeutics, Inc.$52K
plus $97K from 6 others

What the payments were for

Travel & lodging$95837%
Food & beverage$1,63663%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	3	$958
Abbott	21	$886
Actelion Pharmaceuticals US, Inc.	3	$396
Inari Medical, Inc.	2	$227
Bristol Myers Squibb	1	$127

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,594 in reported general payments places this provider in the 85th percentile of 2,212 internal medicine providers in Arizona.

See all internal medicine providers in Arizona →

Other internal medicine in Surprise

Amardeep MajhailSurprise$12K
Frank LovecchioPhoenix$911K
Nasser HajaigPhoenix$687K
Rajesh JanardhananTucson$685K
Mona SelejTucson$440K
Kelly KrohnPhoenix$262K
Jacque SokolovScottsdale$235K
Paul StanderPhoenix$222K
Howard GrossmanPhoenix$131K
Christine HarterGlendale$127K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →